232 related articles for article (PubMed ID: 33755776)
41. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
42. Bronchopulmonary dysplasia in very low birth weight infants.
Demirel N; Bas AY; Zenciroglu A
Indian J Pediatr; 2009 Jul; 76(7):695-8. PubMed ID: 19381510
[TBL] [Abstract][Full Text] [Related]
43. Bronchopulmonary dysplasia predictor scale validation in preterm newborns in two neonatal units at 2600 m above sea level.
Vasquez P; Romero Diaz HA; Gomez Gomez MJ; Leal L; Yejas Navarro LM
Infant Behav Dev; 2018 Aug; 52():1-8. PubMed ID: 29715567
[TBL] [Abstract][Full Text] [Related]
44. Epidemiological factors involved in the development of bronchopulmonary dysplasia in very low birth-weight preterm infants.
Lardón-Fernández M; Uberos J; Molina-Oya M; Narbona-López E
Minerva Pediatr; 2017 Feb; 69(1):42-49. PubMed ID: 25715027
[TBL] [Abstract][Full Text] [Related]
45. Length at birth z-score is inversely associated with an increased risk of bronchopulmonary dysplasia or death in preterm infants born before 32 gestational weeks: A nationwide cohort study.
Jung YH; Park Y; Kim BI; Choi CW
PLoS One; 2019; 14(5):e0217739. PubMed ID: 31150480
[TBL] [Abstract][Full Text] [Related]
46. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants.
Méndez-Abad P; Zafra-Rodríguez P; Lubián-López S; Benavente-Fernández I
Eur J Pediatr; 2019 May; 178(5):755-761. PubMed ID: 30820654
[TBL] [Abstract][Full Text] [Related]
47. Bronchopulmonary dysplasia: risk prediction models for very-low- birth-weight infants.
Valenzuela-Stutman D; Marshall G; Tapia JL; Mariani G; Bancalari A; Gonzalez Á;
J Perinatol; 2019 Sep; 39(9):1275-1281. PubMed ID: 31337853
[TBL] [Abstract][Full Text] [Related]
48. Application of lung ultrasound in monitoring bronchopulmonary dysplasia and pulmonary arterial pressure in preterm infants.
Wang Y; Tan YP; Zhang L; Zheng LN; Han LP; Xie J; Cui Y; Zhang M; An XY
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(13):5964-5972. PubMed ID: 37458628
[TBL] [Abstract][Full Text] [Related]
49. Red cell distribution width as a predictor for bronchopulmonary dysplasia in premature infants.
Go H; Ohto H; Nollet KE; Sato K; Ichikawa H; Kume Y; Kanai Y; Maeda H; Kashiwabara N; Ogasawara K; Sato M; Hashimoto K; Hosoya M
Sci Rep; 2021 Mar; 11(1):7221. PubMed ID: 33790386
[TBL] [Abstract][Full Text] [Related]
50. Plasma Proendothelin-1 as an Early Marker of Bronchopulmonary Dysplasia.
Baumann P; Fouzas S; Pramana I; Grass B; Niesse O; Bührer C; Spanaus K; Wellmann S
Neonatology; 2015; 108(4):293-6. PubMed ID: 26355291
[TBL] [Abstract][Full Text] [Related]
51. Comparison of two novel diagnostic criteria for bronchopulmonary dysplasia in predicting adverse outcomes of preterm infants: a retrospective cohort study.
Wang X; Lu YK; Wu YY; Liu DP; Guo J; Li MC; Wang Y; Li R; Zhang XY; Kang WQ
BMC Pulm Med; 2023 Aug; 23(1):308. PubMed ID: 37612680
[TBL] [Abstract][Full Text] [Related]
52. Platelet is the early predictor of bronchopulmonary dysplasia in very premature infants: an observational cohort study.
Wang X; Ma Y; Wang S; Dong W; Lei X
BMC Pulm Med; 2022 Mar; 22(1):109. PubMed ID: 35346143
[TBL] [Abstract][Full Text] [Related]
53. Bronchopulmonary dysplasia in very low birth weight infants is associated with prolonged hospital stay.
Klinger G; Sirota L; Lusky A; Reichman B
J Perinatol; 2006 Oct; 26(10):640-4. PubMed ID: 17006525
[TBL] [Abstract][Full Text] [Related]
54. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
Potsiurko S; Dobryanskyy D; Sekretar L
BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
[TBL] [Abstract][Full Text] [Related]
55. Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia.
Hsiao CC; Chang JC; Tsao LY; Yang RC; Chen HN; Lee CH; Lin CY; Tsai YG
Pediatr Neonatol; 2017 Feb; 58(1):63-69. PubMed ID: 27321203
[TBL] [Abstract][Full Text] [Related]
56. Lung ultrasound score and diuretics in preterm infants born before 32 weeks: A pilot study.
Alonso-Ojembarrena A; Lechuga-Sancho AM; Morales-Arandojo P; Acuñas-Soto S; López-de-Francisco R; Lubián-López SP
Pediatr Pulmonol; 2020 Dec; 55(12):3312-3318. PubMed ID: 32986302
[TBL] [Abstract][Full Text] [Related]
57. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
58. [A comparison of the clinical diagnosis and outcome in preterm infants with bronchopulmonary dysplasia under two different diagnostic criteria].
Wang CH; Shen XX; Chen MY; Ma XL; Shi LP; Du LZ
Zhonghua Er Ke Za Zhi; 2020 May; 58(5):381-386. PubMed ID: 32392953
[No Abstract] [Full Text] [Related]
59. Bronchopulmonary dysplasia in very and extremely low birth weight infants - analysis of selected risk factors.
Kiciński P; Kęsiak M; Nowiczewski M; Gulczyńska E
Pol Merkur Lekarski; 2017 Feb; 42(248):71-75. PubMed ID: 28258680
[TBL] [Abstract][Full Text] [Related]
60. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
